Delivery Order SPE2DB20D3103-SPE2DB25FN6H7

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,298.19 firm fixed-price delivery order is for the supply of Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of July 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,618.06 delivery order contract is for the supply of Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 5, 2025. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,877.92 firm fixed-price delivery order is for the supply of 4,566,210,161 tablets of Concerta ER 18 mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a significant...
This federal contract award, valued at $24,125.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,568,078,680 tablets of Concerta ER 36mg, a medication used to treat ADHD. The contract is a firm fixed-price, non-set-aside award with a period of performance through April 30, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,242.73 delivery order contract is for the supply of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award has a firm fixed-price pricing type and an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,027.46 Firm Fixed Price Delivery Order contract is for the supply of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,693.32 Firm Fixed Price Delivery Order contract is for the supply of 100 tablets of Concerta ER 18 mg, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a period of performance through February 24, 2025. This award is part of a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,030.21 firm fixed-price delivery order covers the supply of 4,566,338,434 units of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,129.78 firm-fixed-price delivery order is for the supply of Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order valued at $37,308.06, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of January 23, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN6H7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,325.12 Firm Fixed Price Delivery Order contract is for the supply of 4,568,088,839 units of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 1, 2025 and is not set aside for any specific business category.

AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/3/25, 1:36 AM